Related Experiment Video
Updated: May 16, 2026

In Vivo, Percutaneous, Needle Based, Optical Coherence Tomography of Renal Masses
Published on: March 30, 2015
Small renal mass: to treat or not to treat
Ahmed Alasker1, Steve K Williams, Reza Ghavamian
1Department of Urology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY 10467, USA.
Abstract:
An increasing number of small renal masses (SRMs) are being detected with modern cross-sectional imaging. The natural history of SRMs is mostly unknown. Initial active surveillance (AS) is a reasonable treatment option for small renal masses (SRMs) < 4 cm in the infirm patient with major comorbidities. Partial nephrectomy (PN) is the established treatment for T1a tumors, provided that the operation is technically feasible and the tumor can be completely removed. Laparoscopic and, most recently, robotic PN have functional and oncologic outcomes comparable to open PN, but are technically demanding procedures. Radical nephrectomy (RN) should be limited to those cases where the tumor is not amenable to PN. Percutaneous needle biopsy of SRMs can be safely performed and has the potential to characterize SRMs histologically. It is best utilized in conjunction with ablative technologies. However, ablative therapies should be reserved for carefully selected patients who are poor surgical candidates.
Insights
Active surveillance is a viable option for small renal masses under 4cm in elderly patients. Surgical options like partial nephrectomy are preferred for T1a tumors, while radical nephrectomy is reserved for unresectable cases.
Area of Science:
- Urology
- Oncology
- Diagnostic Imaging
Background:
- Modern imaging detects more small renal masses (SRMs), but their natural history is largely unknown.
- Treatment decisions for SRMs require careful consideration of patient health and tumor characteristics.
Purpose of the Study:
- To review current management strategies for small renal masses (SRMs).
- To provide guidance on selecting appropriate treatments for SRMs based on tumor size, patient comorbidities, and technical feasibility.
Main Methods:
- Literature review of studies on small renal mass management.
- Analysis of treatment outcomes for active surveillance, partial nephrectomy, radical nephrectomy, and ablative therapies.
Main Results:
- Active surveillance is suitable for SRMs <4cm in patients with significant comorbidities.
- Partial nephrectomy (PN) is the standard for T1a tumors, with laparoscopic and robotic approaches offering comparable outcomes to open surgery.
- Radical nephrectomy (RN) is reserved for tumors unsuitable for PN.
- Percutaneous biopsy aids in SRM characterization and can be combined with ablative therapies for select patients.
Conclusions:
- Management of SRMs should be individualized, balancing active surveillance, surgical intervention, and ablative therapies.
- Minimally invasive surgical techniques for PN are effective but technically demanding.
- Ablative therapies are best suited for patients who are poor surgical candidates.
Related Concept Videos
Urinary Tract Calculi III: Medical Management
Chronic Kidney Disease III: Interprofessional Care
Urinary Tract Calculi VI: Surgical Management
Nephrotic Syndrome II : Assessment and Medical Management
Kidney Transplant II: Surgical Procedure
Kidney Transplant I: Introduction

